BioCentury
ARTICLE | Clinical News

GalaGen regulatory update

March 21, 1994 8:00 AM UTC

The Arden Hills, Minn., company's Sporidin-G received orphan drug designation from the FDA to treat Cryptosporidium parvum infection of the gastrointestinal tract in immunocompromised patients. Sporid...